Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DMRC | Common Stock | Other | -1.35M | -36.49% | 2.36M | Mar 17, 2025 | See Footnote | F1, F2 | ||
holding | DMRC | Common Stock | 64.7K | Mar 17, 2025 | Direct | ||||||
holding | DMRC | Common Stock | 32.1K | Mar 17, 2025 | See Footnote | F3, F4 |
Id | Content |
---|---|
F1 | On March 17, 2025, TCM Strategic Partners L.P. ("TCM Partners") made an in-kind distribution of an aggregate 1,385,147 shares to certain of its limited partners on a proportionate basis, for no consideration, including 32,081 shares that were distributed in a transaction exempt from Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), pursuant to Rule 16a-13 thereunder. |
F2 | The securities are directly owned by TCM Partners. TCM Strategic GP LLC ("TCM GP") is the general partner of TCM Partners. Riley McCormack is the sole manager of TCM GP. Each of the Reporting Persons disclaims beneficial ownership of such securities except to the extent of its or his indirect pecuniary interest therein, and this report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose. |
F3 | These securities were previously indirectly owned by Riley McCormack through TCM Partners and were distributed to TCM Strategic L.P., an entity wholly owned by Riley McCormack, on March 17, 2025, in a transaction exempt from Section 16 of the Exchange Act pursuant to Rule 16a-13 thereunder. |
F4 | The securities are directly owned by TCM Strategic L.P. Riley McCormack is the founder and sole owner of TCM Strategic L.P. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the securities for purposes of Section 16 of the Exchange Act or for any other purpose. |